All reports

All KCE reports are available in Dutch, French and English under several formats. Form and language of the reports

Publication year:
General domain:
Specific domain:
  1. Icone 304

    Optimisation of RIZIV – INAMI lump sums for incontinence

    KCE Reports 304 (2018) It is estimated that nearly 400,000 people in our country suffer from incontinence of varying degrees. Approximately one-quarter of these persons receive an annual lump sum from INAMI, based on certain conditions.

    https://kce.fgov.be/en/optimisation-of-riziv-%E2%80%93-inami-lump-sums-for-incontinence

  2. Belrai suite of instruments: an exploratory study on applicability for individual care planning and budget allocation in rehabilitation care

    KCE Reports 262 (2016)

    https://kce.fgov.be/en/publication/report/belrai-suite-of-instruments-an-exploratory-study-on-applicability-for-individual-

  3. Autologous breast reconstruction techniques after mammary resection: time measurements for a potential reevaluation of the surgeon fee

    KCE Reports 251 (2015)

    https://kce.fgov.be/en/publication/report/autologous-breast-reconstruction-techniques-after-mammary-resection-time-measurem

  4. Barriers and opportunities for the uptake of biosimilar medicines in Belgium

    KCE Reports 199 (2013)

    https://kce.fgov.be/en/publication/report/barriers-and-opportunities-for-the-uptake-of-biosimilar-medicines-in-belgium

  5. Evolution of day care: impact of financing and regulations

    KCE Reports 192 (2012)

    https://kce.fgov.be/en/publication/report/evolution-of-day-care-impact-of-financing-and-regulations

  6. Optimisation of the operational processes of the Special Solidarity Fund

    KCE Reports 133 (2010)

    https://kce.fgov.be/en/publication/report/optimisation-of-the-operational-processes-of-the-special-solidarity-fund

  7. The reference price system and socioeconomic differences in the use of low cost drugs

    KCE Reports 126 (2010)

    https://kce.fgov.be/en/the-reference-price-system-and-socioeconomic-differences-in-the-use-of-low-cost-drugs

  8. [Feasibility study of the introduction of an all-inclusive case-based hospital financing system in Belgium]

    KCE Reports 121 (2010)

    https://kce.fgov.be/en/publication/report/feasibility-study-of-the-introduction-of-an-all-inclusive-case-based-hospital-fin

  9. International comparison of reimbursement principles and legal aspects of plastic surgery

    KCE Reports 83 (2008)

    https://kce.fgov.be/en/publication/report/international-comparison-of-reimbursement-principles-and-legal-aspects-of-plastic

  10. [Radioisotopes Reimbursement in Belgium]

    KCE Reports 79 (2008)

    https://kce.fgov.be/en/publication/report/radioisotopes-reimbursement-in-belgium

  11. [An evaluation procedure for the emerging medical technologies]

    KCE Reports 44 (2006)

    https://kce.fgov.be/en/publication/report/an-evaluation-procedure-for-the-emerging-medical-technologies

  12. [Evaluation of the Belgian reference reimbursement system]

    KCE Reports 17 (2005)

    https://kce.fgov.be/en/publication/report/evaluation-of-the-belgian-reference-reimbursement-system

  13. [Study of an Alternative Hospital Financing of Blood en Labile Blood Products]

    KCE Reports 12 (2005)

    https://kce.fgov.be/en/study-of-an-alternative-hospital-financing-of-blood-en-labile-blood-products

  14. [Financing of hospital drugs: a descriptive study of several European countries and Canada]

    KCE Reports 8 (2005)

    https://kce.fgov.be/en/publication/report/financing-of-hospital-drugs-a-descriptive-study-of-several-european-countries-and